SUVRETTA CAPITAL MANAGEMENT, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$11,846,000
+30.6%
2,807,000
-13.7%
0.49%
+42.6%
Q2 2022$9,070,000
-44.7%
3,251,048
+13.3%
0.34%
-31.1%
Q1 2022$16,411,000
-27.7%
2,869,048
+15.4%
0.50%
+14.1%
Q4 2021$22,700,000
+42.5%
2,486,340
+66.8%
0.44%
+63.8%
Q3 2021$15,933,000
-31.1%
1,490,4400.0%0.27%
-22.5%
Q2 2021$23,132,000
+182.0%
1,490,440
+194.5%
0.35%
+186.0%
Q1 2021$8,203,000
+647.8%
506,037
+441.2%
0.12%
+303.3%
Q1 2020$1,097,00093,5000.03%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN 18,158$269,00021.76%
TANG CAPITAL MANAGEMENT LLC 2,896,904$42,932,0007.77%
Consonance Capital Management LP 2,005,218$29,717,0003.62%
NEXPOINT ASSET MANAGEMENT, L.P. 721,064$10,686,0002.42%
Congress Park Capital LLC 204,849$3,036,0001.88%
Pekin Hardy Strauss, Inc. 594,913$8,817,0001.80%
PFM Health Sciences, LP 1,872,012$27,743,0001.28%
XTX MARKETS LLC 11,575$172,0000.83%
ArrowMark Colorado Holdings LLC 5,059,526$74,982,0000.72%
DSAM Partners (London) Ltd 261,306$3,873,0000.67%
View complete list of HERON THERAPEUTICS INC shareholders